This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Under-$10 Stocks Set to Soar

BioCryst Pharmaceuticals

One under-$10 name in the biotechnology and drugs complex that could be putting in a bottom here is BioCryst Pharmaceuticals (BCRX - Get Report). This company designs, optimizes and develops novel drugs that block enzymes involved in cancer, viral infections and autoimmune diseases. This stock has taken it on the chin in 2011 with shares off by over 50%.

If you take a look at the chart for BioCryst Pharmaceuticals, you'll notice that this stock has dropped sharply from its October high of $3.33 to a recent low of $2.28 a share. That recent drop has taken the stock down to retest a previous support zone from back in August at around $2.30 a share. If BCRX can manage to hold up around these levels, it could easily be putting in a near-term bottom. This potential bottom could offer a decent risk-to-reward rebound trade since the stock has spiked a number of times up to $3.40 to $3.30, whenever its hit $2.40 to $2.30 in the past few months.

Once could be a buyer of this stock off any noticeable weakness and simply use a mental stop a few percentage points below that $2.30 a share. Look for confirmation of a bottom if we start to see some decent upside volume in the near future. Volume should be considered bullish if the stock is moving higher and it's tracking in close to or above its three-month average action of 162,783 shares. Volume so far today is at 93,000, which is a bit light, so watch to see if that volume gets better into the close, or in the next few trading sessions.

BioCryst Pharmaceuticals is also another heavily shorted name since around 11% of their tradable float is currently sold short by the bears. If this stock is truly putting in a bottom, then look for those bears to cover some of their short positions and lock in profits.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
UPG $1.17 0.00%
CTIC $0.53 0.73%
ACFC $6.39 -0.16%
BCRX $3.32 0.00%
CWTR $0.02 0.87%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs